TY - JOUR
T1 - Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome
AU - Hood, Rebecca L.
AU - Lines, Matthew A.
AU - Nikkel, Sarah M.
AU - Schwartzentruber, Jeremy
AU - Beaulieu, Chandree
AU - Nowaczyk, Małgorzata J.M.
AU - Allanson, Judith
AU - Kim, Chong Ae
AU - Wieczorek, Dagmar
AU - Moilanen, Jukka S.
AU - Lacombe, Didier
AU - Gillessen-Kaesbach, Gabriele
AU - Whiteford, Margo L.
AU - Quaio, Caio Robledo D.C.
AU - Gomy, Israel
AU - Bertola, Debora R.
AU - Albrecht, Beate
AU - Platzer, Konrad
AU - McGillivray, George
AU - Zou, Ruobing
AU - McLeod, D. Ross
AU - Chudley, Albert E.
AU - Chodirker, Bernard N.
AU - Marcadier, Janet
AU - Majewski, Jacek
AU - Bulman, Dennis E.
AU - White, Susan M.
AU - Boycott, Kym M.
PY - 2012/2/10
Y1 - 2012/2/10
N2 - Floating-Harbor syndrome (FHS) is a rare condition characterized by short stature, delayed osseous maturation, expressive-language deficits, and a distinctive facial appearance. Occurrence is generally sporadic, although parent-to-child transmission has been reported on occasion. Employing whole-exome sequencing, we identified heterozygous truncating mutations in SRCAP in five unrelated individuals with sporadic FHS. Sanger sequencing identified mutations in SRCAP in eight more affected persons. Mutations were de novo in all six instances in which parental DNA was available. SRCAP is an SNF2-related chromatin-remodeling factor that serves as a coactivator for CREB-binding protein (CREBBP, better known as CBP, the major cause of Rubinstein-Taybi syndrome [RTS]). Five SRCAP mutations, two of which are recurrent, were identified; all are tightly clustered within a small (111 codon) region of the final exon. These mutations are predicted to abolish three C-terminal AT-hook DNA-binding motifs while leaving the CBP-binding and ATPase domains intact. Our findings show that SRCAP mutations are the major cause of FHS and offer an explanation for the clinical overlap between FHS and RTS.
AB - Floating-Harbor syndrome (FHS) is a rare condition characterized by short stature, delayed osseous maturation, expressive-language deficits, and a distinctive facial appearance. Occurrence is generally sporadic, although parent-to-child transmission has been reported on occasion. Employing whole-exome sequencing, we identified heterozygous truncating mutations in SRCAP in five unrelated individuals with sporadic FHS. Sanger sequencing identified mutations in SRCAP in eight more affected persons. Mutations were de novo in all six instances in which parental DNA was available. SRCAP is an SNF2-related chromatin-remodeling factor that serves as a coactivator for CREB-binding protein (CREBBP, better known as CBP, the major cause of Rubinstein-Taybi syndrome [RTS]). Five SRCAP mutations, two of which are recurrent, were identified; all are tightly clustered within a small (111 codon) region of the final exon. These mutations are predicted to abolish three C-terminal AT-hook DNA-binding motifs while leaving the CBP-binding and ATPase domains intact. Our findings show that SRCAP mutations are the major cause of FHS and offer an explanation for the clinical overlap between FHS and RTS.
UR - http://www.scopus.com/inward/record.url?scp=84862776870&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2011.12.001
DO - 10.1016/j.ajhg.2011.12.001
M3 - Journal articles
C2 - 22265015
AN - SCOPUS:84862776870
SN - 0002-9297
VL - 90
SP - 308
EP - 313
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 2
ER -